Reduction of Hip Arthroscopy Post-operative Pain Using Ultrasound-guided Fascia-iliaca Block
Overview
- Phase
- Phase 4
- Intervention
- ropivicaine
- Conditions
- Hip Dysplasia
- Sponsor
- The Hawkins Foundation
- Enrollment
- 84
- Locations
- 1
- Primary Endpoint
- Visual Analog Scale
- Status
- Completed
- Last Updated
- 7 years ago
Overview
Brief Summary
Patients undergoing a hip scope procedure will be recruited for this study. They will be randomized to either receive a nerve block or no nerve block (pain medicine only). Pain levels and clinical outcomes will be assessed through 3 months post-operatively.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Scheduled for outpatient hip arthroscopy
- •American Society of Anesthesiologists (ASA) 1-3
Exclusion Criteria
- •Prior surgery on ipsilateral hip
- •Chronic narcotic usage over 6 months or more than the equivalent of 20mg of morphine per day
- •Current or prior placement of a spinal cord stimulator or intrathecal pump for pain control purposes
- •Allergy to amide local anesthetics
- •Contraindication to regional anesthesia
- •BMI \> 40
- •Females who are pregnant or plan to get pregnant during the course of the study
Arms & Interventions
FI Block
Fascia iliaca block consisting of up to 60 mL of 0.35% ropivicaine at a dose of 3 mg/kg (with adjuvants of 100 mcg clonidine \[per 60 mL\] and epinephrine 1:400,000)
Intervention: ropivicaine
FI Block
Fascia iliaca block consisting of up to 60 mL of 0.35% ropivicaine at a dose of 3 mg/kg (with adjuvants of 100 mcg clonidine \[per 60 mL\] and epinephrine 1:400,000)
Intervention: clonidine
FI Block
Fascia iliaca block consisting of up to 60 mL of 0.35% ropivicaine at a dose of 3 mg/kg (with adjuvants of 100 mcg clonidine \[per 60 mL\] and epinephrine 1:400,000)
Intervention: Epinephrine
Local Injection
Local anesthetic in the hip joint consisting of 30cc of 0.5% Noropin
Intervention: Noropin
Outcomes
Primary Outcomes
Visual Analog Scale
Time Frame: 3 Months
Pain, as measured by Visual Analog Scale (VAS). Scores are ranged from 0-10, 0 is no pain and 10 is worst possible pain. The unit of measure is units on a scale.
Secondary Outcomes
- Opioid Consumption(3 Months)